How it works
A long-acting amylin analogue acting through calcitonin-receptor/RAMP complexes and studied in satiety and gastric-emptying pathways.
CATALOG ITEM
Cagrilintide
Certificate of analysis (COA)
- Strength
- 5 mg
- Batch number on the certificate (Batch Number)
- CS-ca5-0707
- Analysis date
Identifying details were hidden for privacy. The test results are shown as they appeared in the original report. For research use only.
Cagrilintide: a single material in two strengths
Cagrilintide is listed here as a single material in 5 mg and 10 mg strengths. Each option contains 10 vials, so the options differ in labeled strength rather than vial count. Blends containing Cagrilintide are separate entries with their own composition and documentation to review.
| Labeled strength | Units per pack |
|---|---|
| 5 mg | 10 vials |
| 10 mg | 10 vials |
Select a strength above to see its current pack price. These are catalog specifications, not instructions for use.
Reviewing the Cagrilintide COA
The certificate panel above follows the selected strength. Check the material name, strength, batch number and analysis date on the report. A certificate describes the tested sample and batch; it does not establish results for every pack or other batches.
When no certificate is available for the selected strength, the panel says so. The certificate library includes the available reports and a search by product or batch number.
What it is studied in
Studied for obesity, overweight, increased appetite, and type 2 diabetes.
Key benefits
Satiety, food intake, weight regulation, and combination with GLP-1 pathways.
What sets it apart
A long-acting amylin analogue, a satiety pathway separate from the incretins.